4.6 Article

Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants

Journal

PHARMACEUTICALS
Volume 14, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/ph14020174

Keywords

adjuvant therapies; antimicrobial resistance; cysteine biosynthesis; non-essential targets; serine acetyltransferase

Funding

  1. MSCA-ITN-2014-ETN project INTEGRATE [642620]
  2. Academy of Finland [277001]
  3. Academy of Finland (AKA) [277001, 277001] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Many bacteria and actinomycetales use L-cysteine biosynthesis to increase their tolerance to antibacterial treatment, leading to the onset of antimicrobial resistance, which is a serious threat to public health worldwide. In this study, a series of inhibitors targeting Salmonella thyphimurium serine acetyltransferase (SAT) were developed, showing promising potential, although the most potent compound failed to inhibit bacterial growth in experiments, indicating the need for further research.
Many bacteria and actinomycetales use L-cysteine biosynthesis to increase their tolerance to antibacterial treatment and establish a long-lasting infection. In turn, this might lead to the onset of antimicrobial resistance that currently represents one of the most menacing threats to public health worldwide. The biosynthetic machinery required to synthesise L-cysteine is absent in mammals; therefore, its exploitation as a drug target is particularly promising. In this article, we report a series of inhibitors of Salmonella thyphimurium serine acetyltransferase (SAT), the enzyme that catalyzes the rate-limiting step of L-cysteine biosynthesis. The development of such inhibitors started with the virtual screening of an in-house library of compounds that led to the selection of seven structurally unrelated hit derivatives. A set of molecules structurally related to hit compound 5, coming either from the original library or from medicinal chemistry efforts, were tested to determine a preliminary structure-activity relationship and, especially, to improve the inhibitory potency of the derivatives, that was indeed ameliorated by several folds compared to hit compound 5 Despite these progresses, at this stage, the most promising compound failed to interfere with bacterial growth when tested on a Gram-negative model organism, anticipating the need for further research efforts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available